Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy

Tetsuya Shindo*, Kohei Hashimoto, Atsushi Takahashi, Shintaro Miyamoto, Yasuharu Kunishima, Shunsuke Sato, Fumimasa Fukuta, Yoshiki Hiyama, Akio Takayanagi, Ryuichi Kato, Atsushi Wanifuchi, Yohei Ueki, Manabu Okada, Hideki Adachi, Ko Kobayashi, Toshiaki Tanaka, Naoya Masumori

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry